News Search Results
Oct 16, 2025, 13:50 ET Rubin Rudman Adds Two Associates to Litigation and Trusts and Estates Groups
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin Rudman
Oct 16, 2025, 10:00 ET Lilly confirms date and conference call for third-quarter 2025 financial results announcement
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Oct 16, 2025, 10:00 ET NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), TO SHARE PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2025
Group B.V., is partnered with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace. Safe
More news about: Nordic Pharma
Oct 16, 2025, 10:00 ET NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), TO SHARE PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2025
Group B.V., is partnered with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace. Safe
More news about: Nordic Pharma
Oct 16, 2025, 09:33 ET Meet Caravel: Pioneering a New Era of Biotechnology with the First Unified Platform for Protein Discovery and Delivery
multimedia:https://www.prnewswire.com/news-releases/meet-caravel-pioneering-a-new-era-of-biotechnology-with-the-first-unified-platform-for-protein-discovery-and-delivery-302585999.html
More news about: Caravel Bio
Oct 16, 2025, 09:31 ET Seminal new study on the role of circulating tumour-cell clusters in end-of-life cancer patients underpins strong rationale for cluster dissociation in late-stage disease
About Page Page Therapeutics AG is a Swiss preclinical-stage biotechnology company spun out of ETH Zurich, based on the groundbreaking science of Prof. Nicola Aceto. The company is developing novel therapies
More news about: PAGE Therapeutics AG
Oct 16, 2025, 08:35 ET Unixell Biotech reported a case study of UX-DA001, an iPSC-derived autologous cell therapy for Parkinson Diseases at MDS Congress 2025
1-an-ipsc-derived-autologous-cell-therapy-for-parkinson-diseases-at-mds-congress-2025-302586177.html SOURCE UniXell Biotechnology
More news about: UniXell Biotechnology
Oct 16, 2025, 08:33 ET BridGene Biosciences Raises $28 Million in Series B+ Financing to Accelerate Clinical Development of BGC-515 and Platform Expansion
About BridGene Biosciences BridGene Biosciences is a biotechnology company pioneering the discovery and development of innovative small-molecule drugs that target traditionally undruggable targets. Leveraging its
More news about: BridGene Biosciences
Oct 16, 2025, 08:30 ET Regulatory Writing with Closed-Loop Gen-AI that Protects IP and Saves Time, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 16, 2025, 08:30 ET Deconstructing OCD Through the Use of Multiple Operant Behavioral Tasks in Rodents, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 16, 2025, 08:30 ET Biotech Medical Information: Driving Product Launches and Global Success, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 16, 2025, 08:30 ET How to Measure Patient Experience in Clinical Studies: Driving Retention, Timelines and ROI, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 16, 2025, 08:06 ET The TANAKA Growth Fund Achieves #2 Lipper Ranking for 5-Year Performance Through September 2025
Co-Portfolio Manager of the TANAKA Growth Fund. "This discipline has guided several of our new investments this year in areas like critical minerals, biotechnology, and electric batteries, which are already contributing to performance and have helped drive a 59% year-to-date gain for the Fund versus 15% for
More news about: Tanaka Capital Management
Oct 16, 2025, 08:00 ET BridgePath Scientific Makes a Large Donation to Frederick's First BioMakerSpace
CELLS recently launched the first community biotechnology lab in Frederick County, Md, the CELLS BioMakerSpace, in partnership with and located at the Frederick Innovative Technology Center, Inc. (FITCI).
More news about: Bridgepath Scientific
Oct 16, 2025, 08:00 ET Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery
SOUTH SAN FRANCISCO, Calif., Oct. 16, 2025 /PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, Ph.D., today announced the appointment
More news about: Calico Life Sciences LLC
Oct 16, 2025, 06:05 ET Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine to Broaden U.S. Diabetes Treatment Options
international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian and global biotechnology and pharmaceuticals industries, changes in political conditions in India and changes in
More news about: Biocon Biologics
Oct 16, 2025, 06:00 ET EVOQ Therapeutics Announces Collaboration and License Agreement with Sanofi
CHICAGO, Oct. 16, 2025 /PRNewswire/ -- EVOQ Therapeutics, Inc. (EVOQ), a biotechnology company focused on delivering transformative cures for those living with autoimmune diseases, today announced a Collaboration and License Agreement
More news about: EVOQ Therapeutics, Inc.
Oct 16, 2025, 06:00 ET MLTX INVESTOR ALERT: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
later than December 15, 2025. CASE ALLEGATIONS: MoonLake is a clinical stage biotechnology company that focuses on developing therapies for inflammatory skin and joint diseases. According to the complaint, MoonLake's sole drug candidate
More news about: Robbins Geller Rudman & Dowd LLP
Oct 16, 2025, 05:00 ET Peptilogics Raises $78 Million to Advance Zaloganan Into Pivotal Trial
PITTSBURGH, Oct. 16, 2025 /PRNewswire/ -- Peptilogics, a clinical-stage biotechnology company developing transformative surgical therapeutics to effectively treat and prevent serious medical device infections, today announced the
More news about: Peptilogics
Oct 15, 2025, 23:43 ET VTT identifies new plant-based anti-inflammatory and anti-ageing ingredients for sustainable cosmetics
cosmetic ingredients with scientifically validated biological activity and efficacy. To achieve this, InnCoCells combined advanced plant science, biotechnology, and cultivation methods - including greenhouse, aeroponic and plant cell culture technologies - with circular approaches such as the upcycling
More news about: VTT Info
Oct 15, 2025, 22:27 ET Stockholder Alert: Robbins LLP Informs MoonLake Immunotherapeutics Stockholders that a Class Action Lawsuit was Filed Against the Company
acquired MoonLake Immunotherapeutics (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025. MoonLake is a Swiss clinical-stage biotechnology company focused on inflammatory diseases driven by interleukin-17 (IL-17), particularly in dermatology and rheumatology.
More news about: Robbins LLP
Oct 15, 2025, 17:44 ET Veterinary Industry Leader Dr. Stephen Fisher Joins Anivive Board of Directors
About Anivive Lifesciences Anivive Lifesciences is a pet pharmaceutical company at the forefront of biotechnology, artificial intelligence, and veterinary medicine. Our mission is to transform veterinary healthcare by accelerating the development of novel, affordable
More news about: Anivive Lifesciences Inc.
Oct 15, 2025, 16:00 ET Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its patent for LPT-CBD was allowed in Japan and will be officially granted upon completion of the administrative
More news about: Innocan Pharma Corporation
Oct 15, 2025, 16:00 ET Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its patent for LPT-CBD was allowed in Japan and will be officially granted upon completion of the administrative
More news about: Innocan Pharma Corporation
Oct 15, 2025, 13:20 ET Redefining Clinical Success for Sites Through Patient-Centered Support, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks